Literature DB >> 28117598

CR6-Interacting Factor 1 Deficiency Impairs Vascular Function by Inhibiting the Sirt1-Endothelial Nitric Oxide Synthase Pathway.

Harsha Nagar1,2, Saet-Byel Jung3, Min Jeong Ryu4, Su-Jung Choi1,2, Shuyu Piao1,2, Hee-Jung Song5, Shin Kwang Kang6, Nara Shin2,7, Dong Woon Kim2,7, Seon-Ah Jin8, Jin-Ok Jeong8, Kaikobad Irani9, Byeong Hwa Jeon1,2, Minho Shong3, Gi Ryang Kweon2,4, Cuk-Seong Kim1,2.   

Abstract

AIMS: Mitochondrial dysfunction has emerged as a major contributing factor to endothelial dysfunction and vascular disease, but the key mechanisms underlying mitochondrial dysfunction-induced endothelial dysfunction remain to be elucidated. In this study, we aim at determining whether mitochondrial dysfunction in endothelial cells plays a key role in vascular disease, by examining the phenotype of endothelial-specific CR6-interacting factor 1 (CRIF1) knockout mice. We also used siRNA-mediated downregulation of CRIF1 gene in the endothelial cells to study about the in vitro pathophysiological underlying mechanisms.
RESULTS: Downregulation of CRIF1 in endothelial cells caused disturbances of mitochondrial oxidative phosphorylation complexes and membrane potential, leading to enhanced mitochondrial reactive oxygen species production. Gene silencing of CRIF1 results in decreased SIRT1 expression along with increased endothelial nitric oxide synthase (eNOS) acetylation, leading to reduced nitric oxide production both in vitro and in vivo. Endothelium-dependent vasorelaxation of aortic rings from CRIF1 knockout (KO) mice was considerably less than in wild-type mice, and it was partially recovered by Sirt1 overexpression in CRIF1 KO mice. INNOVATION: Our results show for the first time a relationship between mitochondrial dysfunction and impaired vascular function induced in CRIF1 deficiency conditions and also the possible underlying pathway involved.
CONCLUSION: These findings indicate that CRIF1 plays an important role in maintaining mitochondrial and endothelial function through its effects on the SIRT1-eNOS pathway. Antioxid. Redox Signal. 27, 234-249.

Entities:  

Keywords:  CRIF1; OXPHOS complex; SIRT1; eNOS; mitochondrial dysfunction; nitric oxide

Mesh:

Substances:

Year:  2017        PMID: 28117598     DOI: 10.1089/ars.2016.6719

Source DB:  PubMed          Journal:  Antioxid Redox Signal        ISSN: 1523-0864            Impact factor:   8.401


  9 in total

1.  Endothelial-specific Crif1 deletion induces BBB maturation and disruption via the alteration of actin dynamics by impaired mitochondrial respiration.

Authors:  Min Joung Lee; Yunseon Jang; Jeongsu Han; Soo J Kim; Xianshu Ju; Yu Lim Lee; Jianchen Cui; Jiebo Zhu; Min Jeong Ryu; Song-Yi Choi; Woosuk Chung; Chaejeong Heo; Hyon-Seung Yi; Hyun Jin Kim; Yang H Huh; Sookja K Chung; Minho Shong; Gi-Ryang Kweon; Jun Young Heo
Journal:  J Cereb Blood Flow Metab       Date:  2020-01-27       Impact factor: 6.200

Review 2.  Nitric oxide signalling in cardiovascular health and disease.

Authors:  Charlotte Farah; Lauriane Y M Michel; Jean-Luc Balligand
Journal:  Nat Rev Cardiol       Date:  2018-02-01       Impact factor: 32.419

3.  Sulfur dioxide improves endothelial dysfunction by downregulating the angiotensin II/AT1R pathway in D-galactose-induced aging rats.

Authors:  Jing Dai; Rui Liu; Jinjie Zhao; Aijie Zhang
Journal:  J Renin Angiotensin Aldosterone Syst       Date:  2018 Apr-Jun       Impact factor: 1.636

Review 4.  Abnormal Expression of Mitochondrial Ribosomal Proteins and Their Encoding Genes with Cell Apoptosis and Diseases.

Authors:  Guomin Huang; Hongyan Li; Hong Zhang
Journal:  Int J Mol Sci       Date:  2020-11-23       Impact factor: 5.923

5.  SIRT1 Activation Attenuates the Cardiac Dysfunction Induced by Endothelial Cell-Specific Deletion of CRIF1.

Authors:  Shuyu Piao; Ikjun Lee; Seon-Ah Jin; Seonhee Kim; Harsha Nagar; Su-Jeong Choi; Byeong Hwa Jeon; Cuk-Seong Kim
Journal:  Biomedicines       Date:  2021-01-08

6.  Downregulation of CR6-interacting factor 1 suppresses keloid fibroblast growth via the TGF-β/Smad signaling pathway.

Authors:  Harsha Nagar; Sungmin Kim; Ikjun Lee; Seonhee Kim; Su-Jeong Choi; Shuyu Piao; Byeong Hwa Jeon; Sang-Ha Oh; Cuk-Seong Kim
Journal:  Sci Rep       Date:  2021-01-12       Impact factor: 4.379

7.  CRIF1 deficiency suppresses endothelial cell migration via upregulation of RhoGDI2.

Authors:  Harsha Nagar; Seonhee Kim; Ikjun Lee; Su-Jeong Choi; Shuyu Piao; Byeong Hwa Jeon; Minho Shong; Cuk-Seong Kim
Journal:  PLoS One       Date:  2021-08-26       Impact factor: 3.240

8.  CR6 interacting factor 1 deficiency promotes endothelial inflammation by SIRT1 downregulation.

Authors:  Shuyu Piao; Jun Wan Lee; Harsha Nagar; Saet-Byel Jung; Sujeong Choi; Seonhee Kim; Ikjun Lee; Sung-Min Kim; Nara Shin; Yu Ran Lee; Sang Do Lee; Jin Bong Park; Kaikobad Irani; Minho Won; Gang Min Hur; Byeong Hwa Jeon; Dong Woon Kim; Cuk-Seong Kim
Journal:  PLoS One       Date:  2018-02-23       Impact factor: 3.240

9.  Far-Infrared-Emitting Sericite Board Upregulates Endothelial Nitric Oxide Synthase Activity through Increasing Biosynthesis of Tetrahydrobiopterin in Endothelial Cells.

Authors:  Seonhee Kim; Ikjun Lee; Hee-Jung Song; Su-Jeong Choi; Harsha Nagar; Sung-Min Kim; Byeong Hwa Jeon; Book Sung Kim; Hyun Jong Park; Shuyu Piao; Cuk-Seong Kim
Journal:  Evid Based Complement Alternat Med       Date:  2019-10-31       Impact factor: 2.629

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.